aluates Reports

$ 0.0

Automative

Global Nuclear Medicine Therapy Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-8W14462

Global Nuclear Medicine Therapy Market Research Report 2023

BUY CHAPTERS

Global Nuclear Medicine Therapy Market Research Report 2025

Code: QYRE-Auto-8W14462

Report

July 2025

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Bayer

China Isotope & Radiation

Q BioMed

Curium Pharmaceuticals

Dongcheng

Lantheus

International Isotopes

Jubilant Radiopharma

Aurobindo Pharma

Mundipharma

Nuclear Medicine Therapy Market Size

The global market for Nuclear Medicine Therapy was valued at US$ 2313 million in the year 2024 and is projected to reach a revised size of US$ 6108 million by 2031, growing at a CAGR of 15.1% during the forecast period.

Nuclear Medicine Therapy Market

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine Therapy.

The Nuclear Medicine Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Medicine Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nuclear Medicine Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nuclear Medicine Therapy Market Report

Report Metric	Details
Report Name	Nuclear Medicine Therapy Market
Accounted market size in year	US$ 2313 million
Forecasted market size in 2031	US$ 6108 million
CAGR	15.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Radium-223 Lutetium-177 Iodine-131 Other
Segment by Application	Thyroid Bone Metastasis Lymphoma Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant Radiopharma, Lantheus, Aurobindo Pharma, International Isotopes, Mundipharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Medicine Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nuclear Medicine Therapy Market growing?

Ans: The Nuclear Medicine Therapy Market witnessing a CAGR of 15.1% during the forecast period 2025-2031.

What is the Nuclear Medicine Therapy Market size in 2031?

Ans: The Nuclear Medicine Therapy Market size in 2031 will be US$ 6108 million.

Who are the main players in the Nuclear Medicine Therapy Market report?

Ans: The main players in the Nuclear Medicine Therapy Market are Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant Radiopharma, Lantheus, Aurobindo Pharma, International Isotopes, Mundipharma

What are the Application segmentation covered in the Nuclear Medicine Therapy Market report?

Ans: The Applications covered in the Nuclear Medicine Therapy Market report are Thyroid, Bone Metastasis, Lymphoma, Other

What are the Type segmentation covered in the Nuclear Medicine Therapy Market report?

Ans: The Types covered in the Nuclear Medicine Therapy Market report are Radium-223, Lutetium-177, Iodine-131, Other

Recommended Reports

Nuclear Medicine Markets

Radiotherapy Technologies

Cancer Therapy Devices

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nuclear Medicine Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Radium-223

1.2.3 Lutetium-177

1.2.4 Iodine-131

1.2.5 Other

1.3 Market by Application

1.3.1 Global Nuclear Medicine Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Thyroid

1.3.3 Bone Metastasis

1.3.4 Lymphoma

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nuclear Medicine Therapy Market Perspective (2020-2031)

2.2 Global Nuclear Medicine Therapy Growth Trends by Region

2.2.1 Global Nuclear Medicine Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Nuclear Medicine Therapy Historic Market Size by Region (2020-2025)

2.2.3 Nuclear Medicine Therapy Forecasted Market Size by Region (2026-2031)

2.3 Nuclear Medicine Therapy Market Dynamics

2.3.1 Nuclear Medicine Therapy Industry Trends

2.3.2 Nuclear Medicine Therapy Market Drivers

2.3.3 Nuclear Medicine Therapy Market Challenges

2.3.4 Nuclear Medicine Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nuclear Medicine Therapy Players by Revenue

3.1.1 Global Top Nuclear Medicine Therapy Players by Revenue (2020-2025)

3.1.2 Global Nuclear Medicine Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Nuclear Medicine Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Nuclear Medicine Therapy Revenue

3.4 Global Nuclear Medicine Therapy Market Concentration Ratio

3.4.1 Global Nuclear Medicine Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Therapy Revenue in 2024

3.5 Global Key Players of Nuclear Medicine Therapy Head office and Area Served

3.6 Global Key Players of Nuclear Medicine Therapy, Product and Application

3.7 Global Key Players of Nuclear Medicine Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Nuclear Medicine Therapy Breakdown Data by Type

4.1 Global Nuclear Medicine Therapy Historic Market Size by Type (2020-2025)

4.2 Global Nuclear Medicine Therapy Forecasted Market Size by Type (2026-2031)

5 Nuclear Medicine Therapy Breakdown Data by Application

5.1 Global Nuclear Medicine Therapy Historic Market Size by Application (2020-2025)

5.2 Global Nuclear Medicine Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Nuclear Medicine Therapy Market Size (2020-2031)

6.2 North America Nuclear Medicine Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Nuclear Medicine Therapy Market Size by Country (2020-2025)

6.4 North America Nuclear Medicine Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nuclear Medicine Therapy Market Size (2020-2031)

7.2 Europe Nuclear Medicine Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Nuclear Medicine Therapy Market Size by Country (2020-2025)

7.4 Europe Nuclear Medicine Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Nuclear Medicine Therapy Market Size (2020-2031)

8.2 Asia-Pacific Nuclear Medicine Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Nuclear Medicine Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Nuclear Medicine Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Nuclear Medicine Therapy Market Size (2020-2031)

9.2 Latin America Nuclear Medicine Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Nuclear Medicine Therapy Market Size by Country (2020-2025)

9.4 Latin America Nuclear Medicine Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nuclear Medicine Therapy Market Size (2020-2031)

10.2 Middle East & Africa Nuclear Medicine Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Nuclear Medicine Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Nuclear Medicine Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Details

11.1.2 Bayer Business Overview

11.1.3 Bayer Nuclear Medicine Therapy Introduction

11.1.4 Bayer Revenue in Nuclear Medicine Therapy Business (2020-2025)

11.1.5 Bayer Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Nuclear Medicine Therapy Introduction

11.2.4 Novartis Revenue in Nuclear Medicine Therapy Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 China Isotope & Radiation

11.3.1 China Isotope & Radiation Company Details

11.3.2 China Isotope & Radiation Business Overview

11.3.3 China Isotope & Radiation Nuclear Medicine Therapy Introduction

11.3.4 China Isotope & Radiation Revenue in Nuclear Medicine Therapy Business (2020-2025)

11.3.5 China Isotope & Radiation Recent Development

11.4 Dongcheng

11.4.1 Dongcheng Company Details

11.4.2 Dongcheng Business Overview

11.4.3 Dongcheng Nuclear Medicine Therapy Introduction

11.4.4 Dongcheng Revenue in Nuclear Medicine Therapy Business (2020-2025)

11.4.5 Dongcheng Recent Development

11.5 Q BioMed

11.5.1 Q BioMed Company Details

11.5.2 Q BioMed Business Overview

11.5.3 Q BioMed Nuclear Medicine Therapy Introduction

11.5.4 Q BioMed Revenue in Nuclear Medicine Therapy Business (2020-2025)

11.5.5 Q BioMed Recent Development

11.6 Curium Pharmaceuticals

11.6.1 Curium Pharmaceuticals Company Details

11.6.2 Curium Pharmaceuticals Business Overview

11.6.3 Curium Pharmaceuticals Nuclear Medicine Therapy Introduction

11.6.4 Curium Pharmaceuticals Revenue in Nuclear Medicine Therapy Business (2020-2025)

11.6.5 Curium Pharmaceuticals Recent Development

11.7 Jubilant Radiopharma

11.7.1 Jubilant Radiopharma Company Details

11.7.2 Jubilant Radiopharma Business Overview

11.7.3 Jubilant Radiopharma Nuclear Medicine Therapy Introduction

11.7.4 Jubilant Radiopharma Revenue in Nuclear Medicine Therapy Business (2020-2025)

11.7.5 Jubilant Radiopharma Recent Development

11.8 Lantheus

11.8.1 Lantheus Company Details

11.8.2 Lantheus Business Overview

11.8.3 Lantheus Nuclear Medicine Therapy Introduction

11.8.4 Lantheus Revenue in Nuclear Medicine Therapy Business (2020-2025)

11.8.5 Lantheus Recent Development

11.9 Aurobindo Pharma

11.9.1 Aurobindo Pharma Company Details

11.9.2 Aurobindo Pharma Business Overview

11.9.3 Aurobindo Pharma Nuclear Medicine Therapy Introduction

11.9.4 Aurobindo Pharma Revenue in Nuclear Medicine Therapy Business (2020-2025)

11.9.5 Aurobindo Pharma Recent Development

11.10 International Isotopes

11.10.1 International Isotopes Company Details

11.10.2 International Isotopes Business Overview

11.10.3 International Isotopes Nuclear Medicine Therapy Introduction

11.10.4 International Isotopes Revenue in Nuclear Medicine Therapy Business (2020-2025)

11.10.5 International Isotopes Recent Development

11.11 Mundipharma

11.11.1 Mundipharma Company Details

11.11.2 Mundipharma Business Overview

11.11.3 Mundipharma Nuclear Medicine Therapy Introduction

11.11.4 Mundipharma Revenue in Nuclear Medicine Therapy Business (2020-2025)

11.11.5 Mundipharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Bayer

China Isotope & Radiation

Q BioMed

Curium Pharmaceuticals

Dongcheng

Lantheus

International Isotopes

Jubilant Radiopharma

Aurobindo Pharma

Mundipharma

List of Tables

Table 1. Global Nuclear Medicine Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Radium-223

Table 3. Key Players of Lutetium-177

Table 4. Key Players of Iodine-131

Table 5. Key Players of Other

Table 6. Global Nuclear Medicine Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Nuclear Medicine Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Nuclear Medicine Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Nuclear Medicine Therapy Market Share by Region (2020-2025)

Table 10. Global Nuclear Medicine Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Nuclear Medicine Therapy Market Share by Region (2026-2031)

Table 12. Nuclear Medicine Therapy Market Trends

Table 13. Nuclear Medicine Therapy Market Drivers

Table 14. Nuclear Medicine Therapy Market Challenges

Table 15. Nuclear Medicine Therapy Market Restraints

Table 16. Global Nuclear Medicine Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Nuclear Medicine Therapy Market Share by Players (2020-2025)

Table 18. Global Top Nuclear Medicine Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Therapy as of 2024)

Table 19. Ranking of Global Top Nuclear Medicine Therapy Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Nuclear Medicine Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Nuclear Medicine Therapy, Headquarters and Area Served

Table 22. Global Key Players of Nuclear Medicine Therapy, Product and Application

Table 23. Global Key Players of Nuclear Medicine Therapy, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Nuclear Medicine Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Nuclear Medicine Therapy Revenue Market Share by Type (2020-2025)

Table 27. Global Nuclear Medicine Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Nuclear Medicine Therapy Revenue Market Share by Type (2026-2031)

Table 29. Global Nuclear Medicine Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Nuclear Medicine Therapy Revenue Market Share by Application (2020-2025)

Table 31. Global Nuclear Medicine Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Nuclear Medicine Therapy Revenue Market Share by Application (2026-2031)

Table 33. North America Nuclear Medicine Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Nuclear Medicine Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Nuclear Medicine Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Nuclear Medicine Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Nuclear Medicine Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Nuclear Medicine Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Nuclear Medicine Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Nuclear Medicine Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Nuclear Medicine Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Nuclear Medicine Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Nuclear Medicine Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Nuclear Medicine Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Nuclear Medicine Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Nuclear Medicine Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Nuclear Medicine Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 48. Bayer Company Details

Table 49. Bayer Business Overview

Table 50. Bayer Nuclear Medicine Therapy Product

Table 51. Bayer Revenue in Nuclear Medicine Therapy Business (2020-2025) & (US$ Million)

Table 52. Bayer Recent Development

Table 53. Novartis Company Details

Table 54. Novartis Business Overview

Table 55. Novartis Nuclear Medicine Therapy Product

Table 56. Novartis Revenue in Nuclear Medicine Therapy Business (2020-2025) & (US$ Million)

Table 57. Novartis Recent Development

Table 58. China Isotope & Radiation Company Details

Table 59. China Isotope & Radiation Business Overview

Table 60. China Isotope & Radiation Nuclear Medicine Therapy Product

Table 61. China Isotope & Radiation Revenue in Nuclear Medicine Therapy Business (2020-2025) & (US$ Million)

Table 62. China Isotope & Radiation Recent Development

Table 63. Dongcheng Company Details

Table 64. Dongcheng Business Overview

Table 65. Dongcheng Nuclear Medicine Therapy Product

Table 66. Dongcheng Revenue in Nuclear Medicine Therapy Business (2020-2025) & (US$ Million)

Table 67. Dongcheng Recent Development

Table 68. Q BioMed Company Details

Table 69. Q BioMed Business Overview

Table 70. Q BioMed Nuclear Medicine Therapy Product

Table 71. Q BioMed Revenue in Nuclear Medicine Therapy Business (2020-2025) & (US$ Million)

Table 72. Q BioMed Recent Development

Table 73. Curium Pharmaceuticals Company Details

Table 74. Curium Pharmaceuticals Business Overview

Table 75. Curium Pharmaceuticals Nuclear Medicine Therapy Product

Table 76. Curium Pharmaceuticals Revenue in Nuclear Medicine Therapy Business (2020-2025) & (US$ Million)

Table 77. Curium Pharmaceuticals Recent Development

Table 78. Jubilant Radiopharma Company Details

Table 79. Jubilant Radiopharma Business Overview

Table 80. Jubilant Radiopharma Nuclear Medicine Therapy Product

Table 81. Jubilant Radiopharma Revenue in Nuclear Medicine Therapy Business (2020-2025) & (US$ Million)

Table 82. Jubilant Radiopharma Recent Development

Table 83. Lantheus Company Details

Table 84. Lantheus Business Overview

Table 85. Lantheus Nuclear Medicine Therapy Product

Table 86. Lantheus Revenue in Nuclear Medicine Therapy Business (2020-2025) & (US$ Million)

Table 87. Lantheus Recent Development

Table 88. Aurobindo Pharma Company Details

Table 89. Aurobindo Pharma Business Overview

Table 90. Aurobindo Pharma Nuclear Medicine Therapy Product

Table 91. Aurobindo Pharma Revenue in Nuclear Medicine Therapy Business (2020-2025) & (US$ Million)

Table 92. Aurobindo Pharma Recent Development

Table 93. International Isotopes Company Details

Table 94. International Isotopes Business Overview

Table 95. International Isotopes Nuclear Medicine Therapy Product

Table 96. International Isotopes Revenue in Nuclear Medicine Therapy Business (2020-2025) & (US$ Million)

Table 97. International Isotopes Recent Development

Table 98. Mundipharma Company Details

Table 99. Mundipharma Business Overview

Table 100. Mundipharma Nuclear Medicine Therapy Product

Table 101. Mundipharma Revenue in Nuclear Medicine Therapy Business (2020-2025) & (US$ Million)

Table 102. Mundipharma Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Nuclear Medicine Therapy Picture

Figure 2. Global Nuclear Medicine Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nuclear Medicine Therapy Market Share by Type: 2024 VS 2031

Figure 4. Radium-223 Features

Figure 5. Lutetium-177 Features

Figure 6. Iodine-131 Features

Figure 7. Other Features

Figure 8. Global Nuclear Medicine Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Nuclear Medicine Therapy Market Share by Application: 2024 VS 2031

Figure 10. Thyroid Case Studies

Figure 11. Bone Metastasis Case Studies

Figure 12. Lymphoma Case Studies

Figure 13. Other Case Studies

Figure 14. Nuclear Medicine Therapy Report Years Considered

Figure 15. Global Nuclear Medicine Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Nuclear Medicine Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Nuclear Medicine Therapy Market Share by Region: 2024 VS 2031

Figure 18. Global Nuclear Medicine Therapy Market Share by Players in 2024

Figure 19. Global Top Nuclear Medicine Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Therapy as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Nuclear Medicine Therapy Revenue in 2024

Figure 21. North America Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Nuclear Medicine Therapy Market Share by Country (2020-2031)

Figure 23. United States Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Nuclear Medicine Therapy Market Share by Country (2020-2031)

Figure 27. Germany Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Nuclear Medicine Therapy Market Share by Region (2020-2031)

Figure 35. China Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Nuclear Medicine Therapy Market Share by Country (2020-2031)

Figure 43. Mexico Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Nuclear Medicine Therapy Market Share by Country (2020-2031)

Figure 47. Turkey Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Nuclear Medicine Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Bayer Revenue Growth Rate in Nuclear Medicine Therapy Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Nuclear Medicine Therapy Business (2020-2025)

Figure 52. China Isotope & Radiation Revenue Growth Rate in Nuclear Medicine Therapy Business (2020-2025)

Figure 53. Dongcheng Revenue Growth Rate in Nuclear Medicine Therapy Business (2020-2025)

Figure 54. Q BioMed Revenue Growth Rate in Nuclear Medicine Therapy Business (2020-2025)

Figure 55. Curium Pharmaceuticals Revenue Growth Rate in Nuclear Medicine Therapy Business (2020-2025)

Figure 56. Jubilant Radiopharma Revenue Growth Rate in Nuclear Medicine Therapy Business (2020-2025)

Figure 57. Lantheus Revenue Growth Rate in Nuclear Medicine Therapy Business (2020-2025)

Figure 58. Aurobindo Pharma Revenue Growth Rate in Nuclear Medicine Therapy Business (2020-2025)

Figure 59. International Isotopes Revenue Growth Rate in Nuclear Medicine Therapy Business (2020-2025)

Figure 60. Mundipharma Revenue Growth Rate in Nuclear Medicine Therapy Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Therapeutic Radioisotopes Market Insights Forecast to 2030

Global Radioactive Therapeutic Drugs Market Research Report 2024

Radiopharmaceutical Theranostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nuclear Medicine Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Radiopharmaceutical Therapy Market Research Report 2025

Global Nuclear Medicine Market Research Report 2025

Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025

Global Radioisotopes in Medicine Market Research Report 2025

Global Nuclear Medicine Radiopharmaceuticals Market Research Report 2024

Radiology Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nuclear Medicine Radioisotopes Market Insights Forecast to 2030

Global Diagnostic Nuclear Medicines Market Insights Forecast to 2030

Global Medical Radioisotopes Market Research Report 2025

Nuclear Medicine Science Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nuclear Drug for Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Therapeutic Nuclear Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Therapeutic Nuclear Medicines Market Insights Forecast to 2030

Radiopharmaceuticals for Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Radiopharmaceutical Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions